STRYKER CORP (SYK) FY2024 Q3 P&L / Income Statement

STRYKER CORP (SYK) FY2024 Q3 P&L / Income Statement

Income statement for 2024-07-01 through 2024-09-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

5,494,000,000 US dollars

Cost of sales

1,977,000,000 US dollars

Gross profit

3,517,000,000 US dollars

Total operating expenses

2,432,000,000 US dollars

Operating income

1,085,000,000 US dollars

Other income (expense), net

negative 42,000,000 US dollars

Earnings before income taxes

1,043,000,000 US dollars

Income taxes

209,000,000 US dollars

Net earnings

834,000,000 US dollars

MedSurg and Neurotechnology - Endoscopy

837,000,000 US dollars

MedSurg and Neurotechnology - Instruments

679,000,000 US dollars

MedSurg and Neurotechnology - Medical

938,000,000 US dollars

MedSurg and Neurotechnology - Neuro Cranial

441,000,000 US dollars

MedSurg and Neurotechnology - Neurovascular

329,000,000 US dollars

Orthopaedics and Spine - Hips

420,000,000 US dollars

Orthopaedics and Spine - Knees

570,000,000 US dollars

Orthopaedics and Spine - Other

127,000,000 US dollars

Orthopaedics and Spine - Spine

304,000,000 US dollars

Orthopaedics and Spine - Trauma and Extremities

849,000,000 US dollars

Research, development and engineering expenses

377,000,000 US dollars

Selling, general and administrative expenses

1,896,000,000 US dollars

Amortization of intangible assets

159,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.